Evidence map›Paper›PMID 41599256›Full record

ArticleMolecules (Basel, Switzerland)2026

Study on Comprehensive Quality Control of Herba Hyssopi Based on Chemical Components and Pharmacological Mechanism Action.

Zhenxia Zhao, Jiangning Peng, Yingfeng Du, Xinyi Yang, Lilan Fan, Cong Li, Amatjan Ayupbek, Hui Li, Yongli Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhenxia ZhaoHebei Institute of Drug and Medical Device Inspection, Shijiazhuang 050027, China.ORCID 0009-0007-6319-4569
Jiangning PengHebei Institute of Drug and Medical Device Inspection, Shijiazhuang 050027, China.ORCID 0009-0009-7582-8121
Yingfeng DuCollege of Pharmacy, Hebei Medical University, Shijiazhuang 050017, China.ORCID 0009-0004-1204-3814
Xinyi YangHebei Institute of Drug and Medical Device Inspection, Shijiazhuang 050027, China.
Lilan FanHebei Institute of Drug and Medical Device Inspection, Shijiazhuang 050027, China.
Cong LiHebei Institute of Drug and Medical Device Inspection, Shijiazhuang 050027, China.
Amatjan AyupbekNMPA Key Laboratory for Quality Control of Traditional Chinese Medicine, Uyghur Medicine, XinJiang Uygur Autonomous Region Institute for Drug Control, Urumqi 830054, China.
Hui LiHebei Institute of Drug and Medical Device Inspection, Shijiazhuang 050027, China.
Yongli LiuHebei Institute of Drug and Medical Device Inspection, Shijiazhuang 050027, China.ORCID 0009-0002-4328-4026

Funding

Hebei Province key research and development program 22372503D
6 · The paper itself

Abstract

Herba Hyssopi is a key remedy in Uighur medicine for asthma and cough, frequently used as the monarch or minister herb in prescriptions. However, the lack of effective quality assessment methods complicates the detection of adulteration with common substitutes. In this study, UPLC-LTQ-Orbitrap-MS, network pharmacology, molecular docking, and cell experiments were employed to establish scientific and effective quality control methods to differentiate

Indexed as

Drugs, Chinese HerbalQuality ControlAnimalsChromatography, High Pressure LiquidHumansMolecular Docking SimulationNetwork PharmacologyNitric OxideDrugs, Chinese HerbalNitric Oxidecellular experimentscough and asthmamultivariate chemometric analysisnetwork pharmacologyUPLC-LTQ-Orbitrap-MS

Identifiers

PMID41599256
PMCPMC12844281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.